Management of aortic graft-enteric fistulae  by Menawat, S.S. et al.
Eur J Vasc Endovasc Surg 14 (Supplement A),74-81 (1997) 
Management of Aortic Graft-enteric Fistulae 
S. S. Menawat, P. Gloviczki, R. D. Serry, K. J. Cherry, Jr, T. C. Bower and J. W. Hallett, Jr 
Division of Vascular Surgery, Mayo Clinic, Rochester, U.S.A. 
Introduction 
Aortic graft-enteric fistula (AEF) remains a rare, but 
severe, late complication following aortic re- 
constructions. It has been reported to occur in 0.3-2% 
of the patients who undergo prosthetic reconstruction 
of the abdominal aorta for occlusive or aneurysmal 
disease. >5 Haemorrhagic and septic complications are 
the main causes of early and late mortality, while distal 
acute arterial thrombosis and failure of extra-anatomic 
reconstructions lead to limb loss in a substantial num- 
ber of patients. >29 Aortic graft resection and staged, 
or simultaneous, extra-anatomic bypass (EAB) have 
been advocated by most surgeons, but an increasing 
number of patients undergo in situ reconstruction (ISR) 
following removal of the infected graft with placement 
of a new prosthetic graft, 2°'24'25 aortic homograft, 3°ar- 
terial autograft or autogenous saphenous or femoral 
vein grafts. 31'32 To evaluate the results of current reat- 
ments and define guidelines for optimal management 
of patients with AEF, we have reviewed our own 
experience. 
referring physicians or the current primary care phys- 
icians were contacted by telephone. 
Statistical analysis was performed using Fisher's 
exact test to compare the 30-day mortality rates with 
procedure type (EAB vs. ISR; emergency vs. urgent or 
elective repair), preoperative blood transfusion re- 
quirements (<2 units vs. >2 units) and for clinical 
presentation (bleeding, bleeding together with clinical 
signs of infection and clinical signs of infection alone). 
It was also used to compare the number of active graft 
infections at last follow-up or death between procedure 
types (EAB vs. ISR). Paired comparisons were made 
and p-values were adjusted using the Bonferroni 
method for multiple comparisons. The Kaplan-Meier 
method was used to calculate survival and survival 
free of amputations. Ninety-five percent confidence 
intervals for these rates were also calculated. Com- 
parison of survivals between EAB and ISR for am- 
putation and between the two halves of the study 
period were made using the log-rank test. To calculate 
survival free of amputation patients were censored at 
last follow-up or at death. 
Materials and Methods 
We retrospectively reviewed the clinical data of all 
patients who underwent surgical treatment for AEF 
at the Mayo Clinic between January 1, 1980 and De- 
cember 31, 1994. Patients with primary aortoenteric 
fistula were excluded from this study. Cinical pre- 
sentation, preoperative diagnosis, type of surgical re- 
construction, early and late complications, survival 
and rate of limb salvage were analysed. Recurrence 
of infection was defined as a new onset of clinical 
signs or symptoms of infection (fever, leukocytosis, 
draining wound) in a previously asymptomatic 
patient. Follow-up was obtained from clinical records, 
office correspondence and records of referring phys- 
icians. When necessary, patients, family members or 
Results 
Fifty-two patients, 36 males and 16 females, underwent 
surgical treatment for AEF during the study period. 
The mean age of the patients was 66 years (range: 
35-83). Twenty-five were operated on in the first part 
of the study (January 1, 1980-June 30, 1987) and 27 in 
the second (July 1, 1987-December 31, 1994). This 
group of 52 patients represented 0.95% of the 5442 
patients (aortic aneurysm: 3650, aortoiliac occlusive 
disease: 1792) who underwent aortic reconstruction 
during the same period at the Mayo Clinic. Follow- 
up of the patients surviving 30 days averaged 39 
months (range: 1-181 months). 
Fifteen patients had their initial aortic reconstruction 
1078-5884/97/SA0074+08 $12.00/0 © 1997 W.B. Saunders Company Ltd. 
Management of Aortic Graft-enteric Fistulae 75 
Table 1. Type of initial aortic reconstruction in 52 patients with 
aortic graft-enteric fistula. 
Type of repair Number of 
patients (%) 
Aortic tube graft 3 (6) 
Aortoiliac graft 16 (31) 
Aortofemoral graft 30 (58) 
Aortoiliac graft with visceral 
reconstruction 1 (2) 
Other 2 (4) 
at the Mayo Clinic and 37 at other institutions. This 
accounts for an incidence of 0.3% (15 of 5442) of AEF 
after aortic grafting at our institution. The incidence 
was 0.6% (10 of 1792) after aortic reconstruction for 
occlusive disease and 0.14% (5 of 3650) after re- 
construction for aneurysmal disease, although the real 
number of such complications was presumably higher. 
Indications for initial aortic reconstruction i the 52 
patients included aortoiliac occlusive disease in 30 
patients (58%), aneurysmal disease in 19 (36%) and 
both in two (4%). One patient (2%) underwent aortic 
reconstruction following excision of a malignant re- 
troperitoneal tumour. Aortofemoral bypass was the 
most frequent initial operation performed, followed 
by aortoiliac bifurcation graft and by straight aortic 
graft (Table 1). Thirty-five (67%) proximal aortic ana- 
stomoses were end-to-end and 17 (23%) were end-to- 
side. Twenty-six patients had more than one vascular 
procedure performed before the development of AEF, 
and 10 had a second aortic procedure performed before 
an AEF was diagnosed. Five patients had diabetes, 
but none had a history of steroid therapy, immuno- 
suppression, and none had a history of radiation treat- 
ment. The mean time interval between graft placement 
and diagnosis of AEF was 79 months (range 1-256). 
Twenty-seven patients presented with gastro- 
intestinal bleeding, 19 of these with acute haemorrhage 
(Table 2). Six patients with acute bleeding had a history 
Table 2. Presenting signs and symptoms of 52 patients with aortic 
graft-enteric fistula. 
Sign or symptom Number of 
patients (%) 
Gastrointestinal bleeding 27 (52) 
Leukocytosis 25 (48) 
Fever 19 (37) 
Lower extremity ischaemia 17 (33) 
Malaise 10 (19) 
Drainage through groin wound 
sinus tract 9 (17) 
Graft occlusion 9 (17) 
Septic emboli 4 (8) 
Weight loss 3 (6) 
Pulsatile mass 3 (6) 
Table 3. Diagnostic studies used in 52 patients with aortic graft- 
enteric fistula. 
Name of test Number Positive 
performed result (%) 
US/CT guided aspiration 6 5 (83%) 
Abdominal CT 38 28 (74%) 
Esophagogastroduodenoscopy 26 16 (62%) 
Indium-labelled white cell scan 14 8 (57%) 
Upper GI series 5 2 (40%) 
Colonoscopy 9 1 (11%) 
Aortography 29 1 (3%) 
CT = computed tomography; GI = gastrointestinal; US = ultrasound. 
of chronic bleeding. Twelve patients had at least one 
episode of hypotension with documented systolic 
blood pressure of <90 mmHg. The 27 patients with 
gastrointestinal (GI) bleeding required an average of 7 
units of blood transfusion (range: 1-32) before surgical 
repair of AEF. Thirty-nine patients presented with 
signs or symptoms of infection, while 14 presented 
with both bleeding and infection. 
No test was consistently diagnostic either of 
AEF or of graft infection. Computed tomography 
(CT), aortography and esophagogastroduodenoscopy 
(EGD) were the most frequent diagnostic tests per- 
formed (Table 3). The average number of diagnostic 
studies performed per patient was 2.5. CT or ultra- 
sound (US) guided aspiration was sensitive to diag- 
nose graft infection, but this test was used in six 
patients only (sensitivity: 83%, 5/6). CT scan diagnosed 
graft infection in 74% of the cases studied (Figs. 1-3). 
EGD was the most sensitive to confirm or strongly 
suggest AEF (62%, 16/26). The aortic graft was ob- 
served through the endoscope in 10 patients (38%) 
and a fistula was suspected in an additional six (24%) 
(Fig. 4). The sensitivity of Indiumlll-labelled white cell 
scan to diagnose graft infection was only 57% (8/14). 
The definitive diagnosis of AEF was only made at 
operation in 17 patients (33%). 
Forty-one fistulae occurred in the duodenum, five 
in the jejunum, four in the ileum, one in the sigmoid 
colon and one was not recorded. Ten fistulae were 
localised to the aortic graft anastomosis, 34 were para- 
prosthetic, and in eight patients the site was not re- 
corded. There were 19 emergency operations and 33 
urgent or elective repairs. Forty patients were treated 
with EAB and aortic graft removal (staged: 10, sim- 
ultaneous: 30), 10 with ISR. One patient underwent 
removal of a left aortoiliac graft only and another had 
an attempted repair. In patients receiving EAB the 
outflow artery was common femoral in 26, superficial 
femoral in four, deep femoral in five, and the popliteal 
artery in five. Forty-nine patients had bacteriological 
studies in the perioperative period. The most common 
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Fig. 2. A 70-year-old patient with aortoduodenal fistula 5 years after 
an end-to-side aortobifemoral bypass graft. Arrow indicates air in 
the lumen of the duodenum, which is firmly adherent to the aortic 
graft. Arrowhead indicates absence of fat pad. 
sites of positive cultures were the excised graft and 
the periaortic tissue (91%, 42/46). Blood cultures were 
positive in 17 of 32 patients (53%). The most frequent 
organisms identified were Candida species and the 
most frequent bacteria were enterococci (Table 5). 
Thirty-five patients (71%) had more than one organism 
isolated from cultures. 
Fig. 1. (a) Air (arrow) is identified around the aortic graft in a 70- 
year-old male patient 13 years after aortic aneurysm repair. (b) 
Aortic graft duodenal fistula was identified uring laparotorny. An 
axillofemoral bypass was placed 4 days before aortic graft removal. 
The patient is asymptomatic 41 months after the operation. 
Fig. 3. Air surrounding the right limb of an aortoiliac bypass graft 
(arrowhead) performed 5 years previously in a 79-year-old male 
patient who presented with aortoenteric fistula. Arrows indicate 
the limbs of the graft. 
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Fig. 4. Esophagogastroduodenoscopy visualising the graft material 
(arrow) through the defect in the wall of the fourth portion of the 
duodenum. 
Thirty-day mortality was 27% (14/52) (EAB: 23%, 9/ 
40; ISR: 30%, 3/10; p = 0.69). Mortality after emergency 
repair was 42% (8/19) (EAB: 35%, 5/14; ISR: 50%, 2/ 
4) and it was 18% (6/33) (EAB: 19%, 5/26; ISR: 17%, 
1/6) following urgent or elective repair (p = 0.06). One 
patient died during attempted repair. Preoperative 
blood transfusion (>2 units) was associated with higher 
early mortality (53%, 8/15, p<0.05). Early mortality 
Table 4. Surgical technique in 51 patients with aortic-graft enteric 
fistula. 
Description oftechnique Number 
performed (%) 
Staged: initial bypass then graft removal 9 (17) 
Staged: initial graft removal then bypass 1 (2) 
Simultaneous: bypass, then graft removal 17 (33) 
Simultaneous: graft removal, then bypass 13 (25) 
Complete r moval, in situ reconstruction 5 (10) 
Partial graft removal, in situ reconstruction 5 (10) 
Other 2 (2) 
Table 5. Organisms isolated in culture. 
Organism Number of 
patients (%) 
Candida species 18 (37) 
Enterococci 13 (27) 
Streptococcus viridans 11 (22) 
Enterobacter 8 (16) 
Escherichia coli 6 (12) 
Klebsiella pneumoniae, pseudomonas, Less than 5 
Proteus mirabilis patients each 
was significantly higher among those patients, who 
presented with both bleeding and clinical signs of 
infection (50%, 7/14) compared to those patients with 
clinical signs of infection alone (8%, 2/25) (p<0.05, 
Bonferroni test). Additionally, early mortality trended 
higher in patients with bleeding alone (47%, 9/19) 
compared to patients with clinical signs of infection 
alone (p=0.10, Bonferroni test). Early or late throm- 
bectomy was required in eight patients (EAB: 7; ISR: 
1). Ten patients required early or late graft revision 
(EAB: 9; ISR: 1) (Table 6). There were five early and 
four late amputations in seven patients (13%, 7/52; 
EAB: 15%, 6/40; ISR: 10%, 1/10). One-year survival 
free of amputation was 87% following EAB (95% CI: 
75-100%) and 90% following ISR (95% CI: 69-100%) 
(Fig. 5). Five of the seven patients who required am- 
putation had persistent or recurrent groin infection. 
No late amputation occurred following ISR (Table 6), 
although the follow-up of the seven 30 day survivors 
with ISR averaged only 18 months (range 1 month to 
51 months). Overall 1- and 5-year survivals were 58% 
(95% CI: 45-73%) and 47% (95% CI: 33-66%), re- 
spectively (Fig. 6). One year survival was 36% (95% 
CI: 20-63%) in the first half of the study period and 
77% (95% CI: 61-95%) in the second half (p=0.11). 
There were 14 late deaths, five resulting from sepsis. 
Fourteen persistent or recurrent infections occurred 
following EAB and one following ISR (p = 0.25). Dis- 
ruption of the aortic stump was confirmed in two 
patients (5%, 2/40); both resulted in recurrent AEF 
(acute: 1, chronic erosion: 1). A third recurrent AEF 
was caused by a partially excised graft. At last follow- 
up or at death 24% of the early survivors (9/38) had 
clinical signs of graft infection (EAB: 9/31; ISR: 0/7; 
p=0.16). 
Discussion 
Both the diagnosis and the management of AEF remain 
difficult. The history of chronic GI bleeding in patients 
with aortic prosthesis and negative evaluation for 
other upper or lower GI pathology as bleeding sources 
are clues to the diagnosis. In six of our patients chronic 
blood loss was documented before the diagnosis of 
AEF. In addition to history and physical examination, 
routine blood tests, coagulation tests and cultures, 
in most patients there is time to perform multiple 
diagnostic tests before operation. Those who present 
with signs or symptoms of GI bleeding should undergo 
EGD. Evaluation should include the entire duodenum, 
as the junction of the third and fourth portions is the 
most frequent site of the fistula. The graft material 
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Fig. 5. Survival-free of amputations of 52 patients operated on for aortic-graft enteric fistula. Patients were censored at death or at last 
follow-up. EAB = extra-anatomic bypass; ISR = in situ reconstruction. loo 
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Fig. 6. Survival of 52 patients with aortic-graft enteric fistula. EAB = extra-anatomic bypass; 1SR = in situ reconstruction. 
was  observed  dur ing  EGD in 38% of our  pat ients  
s tud ied  (Fig. 4). Wi th  negat ive  EGD and pers istent ,  
low grade  GI b leed ing,  co lonoscopy  and  upper  GI 
series shou ld  also be per fo rmed,  since the site of AEF 
was  other than the duodenum in 19% of our  pat ients.  
CT w i th  i.v. contrast  shou ld  be done  in all haemo-  
dynamica l ly  stable pat ients,  as it may conf i rm per igraf t  
f luid, haematoma,  pseudoaneurysm,  and  absence of 
fat p lane between the graft  and duodenum (Figs. 1-3). 
In these pat ients  the presence of air a round the graft  
and  outs ide the bowel  lumen is h igh ly  suggest ive  of 
AEF  and is d iagnost ic  of infection if found more  than 
30 days  fo l lowing aort ic reconstruct ion.  Asp i ra t ion  
of the per igraf t  f luid under  CT or US guidance,  if 
successful,  has h igh  sensi t iv i ty  to conf i rm infection. 
Ind ium 111 whi te  cell scan in our  exper ience was  falsely 
negat ive in 43% of the pat ients.  Rad ionuc l ide  scanning 
us ing 99mTc by  others,  however ,  showed s igni f icant ly 
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higher sensitivity to diagnose aortic graft infection. 33 
Aortography is performed to exclude other sources of 
GI bleeding, to define vascular anatomy and to plan 
the vascular reconstruction. No test is consistently 
accurate to diagnose AEF. EGD can, however, confirm 
the diagnosis if the graft material is observed through 
the endoscope. Upper GI series is also diagnostic if 
contrast is identified outside the bowel around the 
prosthetic graft. The difficulty in diagnosing AEF was 
evident in our series as one-third of the patients had 
the diagnosis established at laparotomy. 
Surgical treatment of AEF remains challenging and 
survival is affected by acuteness of the presentation 
and by bleeding and infection. Those few patients, who 
present with uncontrollable sudden bleeding have no 
chance of survival without laparotomy. The classic 
and most frequently used treatment of AEF has been 
extra-anatomic revascularisation of the lower ex- 
tremities followed by simultaneous or staged lap- 
arotomy. The duodenal fistula is repaired by direct, 
two-layer closure, followed by resection of the infected 
graft, debridement of all infected tissue and over- 
sewing of the infrarenal aor t i c  stump. 2-5'7-10'1~I9'21-29 If 
emergency operation is performed for acute bleeding, 
or the diagnosis of AEF is uncertain, laparotomy with 
graft removal and fistula repair is done first. If bleeding 
is low grade, or if the patient appears to tolerate the 
simultaneous operation without significantly added 
risk, in our practice extra-anatomic revascularisation 
is done first, followed immediately by laparotomy and 
graft removal. In stable patients with multiple risk 
factors, however, staged procedure is preferred, per- 
forming extra-anatomic revascularisation first, fol- 
lowed by laparotomy within 48-72 h. Mortality, early 
and late morbidity, including limb loss and stump 
blow-out following EAB, remain significant. In a series 
of 43 patients with AEF, Reilly et al. 18 reported a 
19% early mortality and a 26% rate of recurrent graft 
infection. Kuestner et al. 29 from the same institution 
recently reported a 19% early mortality, 9% aortic 
stump disruption and 9% amputation rate in 31 
patients. In our series, early mortality after EAB was 
27%, aortic disruption occurred in 5%, and the overall 
amputation rate was 15%. 
The first large series of patients with AEF treated 
with ISR was reported by Walker et al. 2° In that series, 
Dacron grafts (woven in 5 and knitted in 18) were 
used for aortic replacement. Kieffer et al. 3° used aortic 
homografts for in situ replacement in nine patients 
with AEF, while others have reported using arterial 
autografts, 31 or autogenous vein grafts using the sa- 
phenous or femoral ve ins .  32 More recently, ex- 
perimental nd clinical experience has increased with 
the use of antibiotic bonded zero porosity Dacron 
grafts24-38 
The study by Walker et al. 2° included 23 patients 
with AEF with an early mortality of 22% and no late 
limb loss. The best results following in situ replacement 
are achieved in those patients who have negative 
cultures. 25 Of the 10 patients in our series that had 
ISR, early mortality was 30%. However, only one 
patient had early amputation and none had late limb 
loss, recurrent infection or graft-related complications 
during a mean follow-up of 18 months. If the patient 
is septic or extensive graft infection with perigraft 
abscess is diagnosed preoperatively, extra-anatomic 
reconstruction is preferred, staged or simultaneous, 
before complete removal of the infected graft. Other- 
wise, in situ reconstruction is performed, following 
excision of all infected tissues and local irrigation with 
antibiotic solution. The new prosthesis is wrapped 
with omentum and suction drains are placed in the 
retroperitoneum. All patients are maintained on long- 
term antibiotic treatment, including adequate coverage 
of Candida species if grown in cultures. 
Conclusion 
Our study has confirmed that outcome of patients 
with AEF has improved in recent years. Mortality, 
limb loss and infectious complications are, however, 
still high. Those presenting with bleeding, together 
with clinical signs of infection, have high mortality. 
ISR, performed in selected patients, appears to result 
in less late complications. 
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